New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

被引：0
|
作者：
Assi, Rita [1 ]
Temraz, Sally [1 ]
Shamseddine, Ali [1 ]
Mukherji, Deborah [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Hematol Oncol, Beirut, Lebanon
来源：
CURRENT DRUG TARGETS | 2016年 / 17卷 / 03期
关键词：
Prostate cancer; androgen receptor; abiraterone; enzalutamide; LIGAND-INDEPENDENT ACTIVATION; CIRCULATING TUMOR-CELLS; ABIRATERONE ACETATE; ENZALUTAMIDE RESISTANCE; GENE AMPLIFICATION; ANTITUMOR-ACTIVITY; SPLICE VARIANTS; TYROSINE PHOSPHORYLATION; INCREASED SURVIVAL; AR COREGULATORS;
D O I：
10.2174/1389450116666150907101044
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The androgen receptor (AR) signalling pathway remains a key driver of prostate cancer progression despite castrate levels of testosterone in advanced disease. The androgen biosynthesis inhibitor abiraterone and the anti-androgen enzalutamide have been shown to prolong survival in randomized clinical trials both pre- and post-docetaxel chemotherapy and are now in routine clinical use. With the use of these drugs and other novel survival-prolonging therapeutics, patients with advanced prostate cancer are now living longer with better quality of life. This article will review pre-clinical and clinical data for AR-targeting therapeutics for advanced prostate cancer with a focus on mechanisms of resistance and future directions for research.
引用
收藏
页码：290 / 302
页数：13
相关论文
共 50 条
  • [1] Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
    Antonarakis, Emmanuel S.
    Chandhasin, Chandtip
    Osbourne, Erica
    Luo, Jun
    Sadar, Marianne D.
    Perabo, Frank
    ONCOLOGIST, 2016, 21 (12): : 1427 - 1435
  • [2] Targeting the androgen receptor signaling pathway in advanced prostate cancer
    Chung, Clement
    Abboud, Karen
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (15) : 1224 - 1235
  • [3] Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment
    Shah, Harsh
    Vaishampayan, Ulka
    TARGETED ONCOLOGY, 2018, 13 (06) : 679 - 689
  • [4] Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment
    Harsh Shah
    Ulka Vaishampayan
    Targeted Oncology, 2018, 13 : 679 - 689
  • [5] New Opportunities for Targeting the Androgen Receptor in Prostate Cancer
    Centenera, Margaret M.
    Selth, Luke A.
    Ebrahimie, Esmaeil
    Butler, Lisa M.
    Tilley, Wayne D.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (12):
  • [6] New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
    Sural, Yavuz Selim
    Cal, Cag
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 106 - 110
  • [7] Targeting the androgen receptor in prostate cancer
    Culig, Zoran
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1427 - 1437
  • [8] New Approaches to Targeting the Androgen Receptor Pathway in Prostate Cancer
    Velho, Pedro Isaacsson
    Bastos, Diogo Assed
    Antonarakis, Emmanuel S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 228 - 240
  • [9] Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
    Kohli, Manish
    Qin, Rui
    Jimenez, Rafael
    Dehm, Scott M.
    ADVANCES IN UROLOGY, 2012, 2012
  • [10] Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer
    Knudsen, Karen E.
    Kelly, William Kevin
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 483 - 493
12345